AcuTemp unit remains the only FAA-approved container for domestic US use
Continental Airlines Cargo has made a “selection” of the AcuTemp RKN container for use on its cargo jets, says CSafe LLC (Dayton, OH) in a recent announcement. CSafe is the marketing j.v. between AcuTemp Thermal Systems (Dayton, OH) and AmSafe, Inc. (Phoenix), the two companies that developed the RKN unit. “Our selection by Continental reinforces CSafe’s position as a premier player in the active temperature marketplace and expands customers’ options for temperature critical transportation,” said Steve Boyd, CSafe director of business development.
But the real story here might be Continental’s aggressive positioning to capture more of the cold chain market. Last fall, Continental became the first cargo air carrier to be qualified internationally under a “Qualified Envirotainer Provider Training” (QEP) program run by Envirotainer (Lagga Marma, Sweden), which happens to be the only direct competitor to CSafe. “Continental is determined to offer our customers the most advanced cold-chain technology available,” said Mark Mohr, Continental’s manager, product development and specialty sales. “The AcuTemp RKN represents the latest addition to our ever-growing arsenal of temperature-sensitive shipping capabilities.”
Envirotainer’s and CSafe’s containers are unit-load devices that contain a pallet-sized (more or less) shipment of pharmaceuticals. Both can be “active,” meaning that they have onboard refrigerators (or, if necessary, heaters) that can be powered from batteries or plugged in. (Similar “passive” devices use dry ice or refrigerated phase-change material to maintain temperature). CSafe’s unit is FAA-rated; Envirotainer’s, although on the market longer, await FAA approval.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.